: He criticized then-Health Minister Jean-Yves Duclos for intervening on behalf of the pharmaceutical industry by asking the board to suspend consultations on new pricing guidelines.

: Herder noted that the federal government delayed the introduction of new pricing regulations four separate times, accepting industry claims that more time was needed.

In February 2023, , a member of Canada’s Patented Medicine Prices Review Board (PMPRB) , resigned in a blistering letter to the federal government. Herder , a health law expert at Dalhousie University , accused the Liberal government of failing to support "real change" and undermining the regulator's independence to favor the pharmaceutical industry. Key Reasons for Resignation

: Herder stated the government’s actions were "largely indistinguishable in form and substance from industry talking points," leaving the regulator in an "endless tunnel with no light". Context and Fallout